Strata Critical Medical (SRTA) Preferred Stock Liabilities (2019 - 2021)

Strata Critical Medical (SRTA) has 3 years of Preferred Stock Liabilities data on file, last reported at $225.0 million in Q1 2021.

• Preferred Stock Liabilities for Q1 2021 came in at $225.0 million, down 10.82% year-over-year; the trailing twelve-month figure through Mar 2021 was $225.0 million (down 10.82% YoY), and the FY2020 annual result was $226.1 million, changed N/A from the prior year.
• Preferred Stock Liabilities steadied at $225.0 million in Q1 2021 per SRTA's latest filing, from $226.1 million in the prior quarter.
• Over five years, Preferred Stock Liabilities peaked at $252.3 million in Q1 2020 and troughed at $225.0 million in Q1 2021.
• A 3-year average of $241.2 million and a median of $244.6 million in 2020 frame the typical range for Preferred Stock Liabilities.
• The sharpest annual moves came in 2020 and 2021: Preferred Stock Liabilities grew 0.24% in 2020, then fell 10.82% in 2021.
• A 3-year view of Preferred Stock Liabilities shows it stood at $246.6 million in 2019, then slipped by 8.32% to $226.1 million in 2020, then slipped by 0.48% to $225.0 million in 2021.
• Business Quant data shows SRTA's Preferred Stock Liabilities at $225.0 million in Q1 2021, $226.1 million in Q4 2020, and $244.6 million in Q3 2020.